Analysts expect Genmab A/S to report revenue of 1.13 B for Q3 26, against a range of 1.07 B to 1.19 B. The most recent reported quarter, Q2 26, came in at 1.16 B, a 0.5% miss against the 1.17 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 803.04 M | 895.80 M | 715.00 M | 925.00 M | 1.02 B | 1.06 B | 896.00 M | 1.16 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 834.71 M | 925.20 M | 809.03 M | 974.86 M | 1.12 B | 1.17 B | 903.51 M | 1.25 B | 1.19 B | 1.25 B | 1.17 B | 1.44 B | 1.55 B | 1.48 B | 1.36 B | 1.80 B | ||||||||||
| Low Estimate | 746.21 M | 795.05 M | 702.99 M | 876.05 M | 920.26 M | 1.02 B | 812.99 M | 1.09 B | 1.07 B | 1.18 B | 1.05 B | 1.30 B | 1.33 B | 1.30 B | 1.26 B | 1.51 B | ||||||||||
| Consensus Estimate | 790.46 M | 860.12 M | 756.01 M | 925.46 M | 1.02 B | 1.09 B | 858.25 M | 1.17 B | 1.13 B | 1.21 B | 1.11 B | 1.37 B | 1.44 B | 1.39 B | 1.31 B | 1.66 B |
Analysts expect Genmab A/S to report earnings per share of 0.36 for Q3 26, against a range of 0.34 to 0.38. The most recent reported quarter, Q2 26, came in at 0.49, a 44.1% beat against the 0.34 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.29 | 0.85 | 0.30 | 0.54 | 0.65 | 0.05 | 0.08 | 0.49 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.33 | 0.36 | 0.24 | 0.44 | 0.49 | 0.31 | 0.18 | 0.36 | 0.38 | 0.31 | 0.21 | 0.46 | 0.56 | 0.62 | 0.35 | 0.77 | ||||||||||
| Low Estimate | 0.27 | 0.34 | 0.20 | 0.40 | 0.43 | 0.27 | 0.16 | 0.32 | 0.34 | 0.29 | 0.17 | 0.42 | 0.46 | 0.58 | 0.31 | 0.67 | ||||||||||
| Consensus Estimate | 0.30 | 0.35 | 0.22 | 0.42 | 0.46 | 0.29 | 0.17 | 0.34 | 0.36 | 0.30 | 0.19 | 0.44 | 0.51 | 0.60 | 0.33 | 0.72 |
Pull Wall Street consensus for Genmab A/S (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=GMAB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "GMAB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=GMAB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();